Cannabis policy has always been a little messy. State by state, rule by rule, with a whole lot of gray in between. But right now, something big is shifting at the federal level with DEA rescheduling of cannabis.
The proposed rescheduling of cannabis could shift how cannabis is viewed under the Controlled Substances Act, and that matters to everyone in the canna industry, including you.
This isn’t full legalization. It’s not a flip-the-switch moment. But it is a meaningful step that could reshape research, taxes, and how the cannabis industry operates moving forward.
understanding the DEA rescheduling
Right now, cannabis is classified as a Schedule I controlled substance. That category is reserved for substances with a high potential for abuse and no currently accepted medical use under federal standards.
The Drug Enforcement Administration is proposing to move cannabis to Schedule III, which would reclassify it as a Schedule III drug. That shift signals something important. It acknowledges that cannabis may have accepted medical use and a different risk profile than previously defined.
Schedule III substances still come with regulation. They are not fully unrestricted. But they are treated differently from Schedule I drugs when it comes to research, prescribing, and oversight.
This proposal is part of a formal process. It gets published in the Federal Register, opens up for public comment, and may go through hearings before a final decision is made.
For now, nothing changes overnight. Cannabis is still Schedule I until that process is complete.
federal laws about cannabis
Under federal law, cannabis is still illegal if it contains more than 0.3 percent THC by dry weight. That rule exists even though many states allow medical marijuana or recreational marijuana use.
The Department of Justice and DEA still have the authority to enforce federal law, especially on federal property or across state lines.
At the same time, enforcement priorities have shifted over the years. Different administrations have taken different approaches, which is part of why things feel inconsistent.
clashing state and federal laws
This is where things get complicated.
Many states have passed their own marijuana laws, allowing for legalized medical cannabis, adult use, or both. That means state legal marijuana operations can exist legally at the state level while still conflicting with federal rules.
For consumers, it can feel normal. You walk into a dispensary, buy a product, and go about your day. But behind the scenes, businesses are navigating banking limits, tax restrictions, and compliance risks because of that federal disconnect. This gap also blocks interstate commerce. Even if two states have legal cannabis, products can’t legally move between them. Everything stays siloed.
Until federal policy changes, this tension remains a defining part of the cannabis experience in the United States.
the role of the supreme court in shaping cannabis policy
The Supreme Court of the United States has played an ongoing role in shaping cannabis policy, even without directly legalizing it.
Courts continue to influence how marijuana laws are applied, especially when it comes to licensing, state market rules, and who is allowed to participate in the industry. Legal challenges have shaped everything from residency requirements to how states structure their cannabis programs.
These decisions affect how the cannabis industry operates day to day. They also impact access, equity programs, and how states balance their own regulations with federal law. As policy evolves, the courts remain a key part of how cannabis laws are interpreted and enforced across the country.
congressional response and activity
The proposed reschedule hasn’t gone unnoticed in Congress. Lawmakers like Chuck Schumer and Ron Wyden have supported rescheduling marijuana as part of broader reform efforts.
There are also ongoing legislative pushes that could change things further:
The MORE Act focuses on removing cannabis from federal scheduling entirely and addressing equity in the cannabis industry. The SAFE Banking Act aims to give cannabis businesses access to traditional financial systems.
Updates to the Farm Bill could redefine hemp and clarify rules around synthetically derived THC.
None of these is guaranteed. But together, they show a clear direction. Federal policy is starting to catch up with reality.
tax implications of the reschedule
Right now, cannabis businesses are subject to Section 280E, which means they can’t take standard tax deductions because they are considered to be trafficking a Schedule I controlled substance.
If cannabis becomes a Schedule III substance, that changes. Businesses would be able to deduct operating costs, as other industries do. That shift could ease pressure across the marijuana industry, especially for smaller operators trying to stay competitive. It also opens the door for more sustainable growth.
the future of cannabis research and development
Research has been one of the biggest limitations under the current policy. Because cannabis is Schedule I, researchers face strict controls when studying it. Access to materials is limited, and approval processes are slow. Rescheduling could expand cannabis research significantly. It would allow scientists to study better medical use, dosing, and long-term effects based on current scientific knowledge.
Agencies like the Food and Drug Administration would play a larger role in evaluating cannabis-based treatments under the Federal Food Drug and Cosmetic Act.
This could lead to more clarity around medicinal cannabis, including how it interacts with the body and where it fits into healthcare.
controlled substance classification and its impact
The Controlled Substances Act lays out five categories based on risk and medical value.
To qualify for Schedule III, a substance must have a lower potential for abuse than Schedule I or II drugs and show currently accepted medical use. It also considers physical dependence and psychological dependence levels.
Moving cannabis into this category would reflect a shift in how the federal government views the plant. It would align policy more closely with what many states and researchers already recognize.
the economics of cannabis legalization
Cannabis is already a major economic force. State markets generate billions in revenue and support thousands of jobs.
New York, for example, has projected a multi-billion-dollar adult-use market with significant job creation and economic output. Similar patterns are showing up across other regions, including the District of Columbia.
Rescheduling could support even more growth by easing tax burdens and improving access to banking and investment. For the broader cannabis industry, that means more stability and more opportunity to scale responsibly.
what this means for cannabis brands
The DEA rescheduling conversation has cooled a bit in the headlines, but it still matters. Policy changes like this move slowly, and the real impact tends to show up over time. For brands, this moment is less about reacting and more about paying attention to where things are going.
If cannabis shifts to Schedule III, the ripple effects could change how brands operate across the board. Tax relief alone could give companies more room to invest in product quality, research, and long-term growth. That matters for both newer operators and established names in the space.
Brands like Stiiizy, PlugPlay, Cake, and She Hits Different are all operating in a system shaped by federal prohibition, even if their products are sold legally at the state level. Changes to federal classification could impact how these brands scale, how they handle compliance, and how they show up in new markets over time.
There’s also the question of interstate commerce. Right now, brands are locked into state-by-state operations. If federal policy continues to shift, that could open the door to broader distribution and more consistent branding across regions.
At the same time, nothing changes overnight. Even with rescheduling marijuana, there are still layers of regulation, federal law, and agency oversight to work through. The formal rulemaking process takes time, and brands will need to stay flexible as the landscape evolves.
For now, the focus is on stability. Build strong operations, stay compliant, and be ready for a future that may look more connected than the one we have today.
